Chemoimmunotherapy Ups PFS in Early-Stage Follicular Lymphoma

TROG 99.03 constitutes “the only high level evidence currently available to guide decision making for this group of patients,” says investigator Michael MacManus.

Source: CancerNetwork - July 18, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news